This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Jan 1;77(1):E7.

doi: 10.1002/hep.32673. Epub 2022 Jul 26.

Reply

Margarita Papatheodoridi¹, Anna S Lok², George V Papatheodoridis¹

Affiliations

Affiliations

¹ Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens , General Hospital of Athens "Laiko" , Athens , Greece.
² Division of Gastroenterology and Hepatology , University of Michigan , Ann Arbor , Michigan , USA.

PMID: 35856177
DOI: 10.1002/hep.32673

Reply

Margarita Papatheodoridi et al. Hepatology. 2023.

. 2023 Jan 1;77(1):E7.

doi: 10.1002/hep.32673. Epub 2022 Jul 26.

Authors

Margarita Papatheodoridi¹, Anna S Lok², George V Papatheodoridis¹

Affiliations

¹ Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens , General Hospital of Athens "Laiko" , Athens , Greece.
² Division of Gastroenterology and Hepatology , University of Michigan , Ann Arbor , Michigan , USA.

PMID: 35856177
DOI: 10.1002/hep.32673

No abstract available

PubMed Disclaimer

References

REFERENCE

1. Papatheodoridi M, Tampaki M, Lok AS, Papatheodoridis GV. Risk of HBV reactivation during therapies for HCC: a systematic review. Hepatology. 2022;75:1257–74.

LinkOut - more resources

Full Text Sources